$CNAT Conatus Pharmaceuticals Receives Approval From Nasdaq Stock Market To Transfer Listing Of Stock From Nasdaq Global Market To Nasdaq Capital Market. CONATUS PHARMACEUTICALS- HAS BEEN GRANTED ADDITIONAL TIME UNTIL MAY 25 TO REGAIN COMPLIANCE WITH MINIMUM $1.00PER SHARE REQUIREMENT FOR LISTING ON NASDAQ
  • 2
  • 4